NCT07281131
Testing the Impact of Pre-visit Priming for Medications
Enrolling by Invitation
NAAges 65+InterventionalHealth servicesBrigham and Women's HospitalInvestigator-initiated
~1,700 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Pre-visit prompts
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Completion of medication prescribing/deprescribing target on day of PCP visit
Measured over 1 day
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
≥65 years of age
Have an upcoming clinic appointment with a BWH PCP at one of the included clinics
Exclusion
Documented allergy to one of the components (statin)
Current or recent prescription for a statin or PCSK9-inhibitor or bempedoic acid
Primary language recorded other than English or Spanish
What this trial measures
- Completion of medication prescribing/deprescribing target on day of PCP visit1 day
The primary clinical outcome will be measured on the day of the primary care provider (PCP) visit through EHR data, depending on medication target: a) discontinuation or taper, or b) statin prescribing.